Skip to main content
. 2018 Apr 15;465:4–26. doi: 10.1016/j.mce.2017.08.016

Table 2.

Serum concentrations of C19steroids determined by liquid chromatography tandem mass spectrometry. All concentrations are shown in nmol/L except for DHEA sulfate (DHEAS), which are shown in the micromolar range. The details of the original studies are given in the footnotes below the table.

Androgen precursors Women Men Androgen metabolites Women Men
DHEA 4.2–11.8a 6.9–30c Androsterone (AST) 0.4–2.1c 0.9–1.9c
6.3–35.4c 15.8g 0.5 ± 0.03d 0.7 ± 0.03d
3.4 ± 0.03d 4.1 ± 0.1d AST-sulfate ndd 19 ± 1.6d
10–20j 1250–2500j
DHEA sulfate 3400–9600a 1312–14125c AST-glucuronide 28–467c 59–248c
701–8965c 5709g 89 ± 0.7d 104 ± 1.4d
3337 ± 16d 3247 ± 50d 2.1–170e 86–150h
4300–5400j EpiAST 0.6 ± 0.03d 0.3 ± 0.02d
A4 3.3–9.2a 2.3–5.5c EpiAST-sulfate 123±3d 105 ± 3.2d
1.2–2.82b 3.64g 500–850j
1.1–8.7c EpiAST-glucuronide 78 ± 0.4d 76 ± 1.3d
5-androstenediol (5-diol) 1.5 ± 0.07d 1.7 ± 0.2d 3α-androstanediol
(3α-adiol)
nqd 0.2 ± 0.02d
5-diol-sulfate 215 ± 21d 178 ± 10d 3α-adiol-sulfate ndd ndd
250–500j 3α-adiol-3-glucuronide 0.6–8.4c 1.3–6.7c
5α-androstanedione 0.5–2.6c 1.0–1.5c 0.5–9.2e 2.0–3.8h
11OHA4 4.9–12.5a 2.3–5.1i 3α-adiol-17-glucuronide 0.3–10c 6.2–8.8c
11KA4 2–3.9a 0.7–1.4i 0.5–12e 5.4–11h
11OHT 0.1–0.3a 0.3–0.7i DHEA-glucuronide 0.9 ± 0.001d 0.7 ± 0.03d
7αOH-DHEA 0.08–1.4f
Active Androgens 7βOH-DHEA 0.08–0.9f
T 0.2–0.5a 7.4–14c 7-oxo-DHEA 0.03–0.6f
0.58–1.1b 16.85g 16OH-DHEA-sulfate 100–200j
0.4–4.1c 15.6 ± 0.6d T-sulfate ndd ndd
1.1 ± 0.09d 10–20j T-glucuronide 0.8 ± 0.02d 26.5 ± 0.1d
Calculated free T 0.0056–0.0122b 0.3780g DHT-sulfate 0.3–2.7c 2.5–3.5c
DHT 0.2–0.9c 0.9–2c ndd ndd
0.4–0.01d 1.2 ± 0.09d DHT-glucuronide ndd ndd
11KT 1.2–1.8a 1.0–2.6i 5-diol-glucuronide nqd nqd
a

O'Reilly et al. (2016), interquartile range, n = 49, age interquartile range 23–32.

b

Haring et al. (2012), interquartile range, n = 985, age 20-80.

c

Trabert et al. (2016), min-max, pre- and postmenopausal women, n = 15.

d

Zang et al. (2017), mean ± standard deviation for triplicate of pooled commercial serum.

e

Labrie et al. (2006), min-max, pre- and postmenopausal women, n = 424.

f

Ke et al. (2016), min-max, pre- and postmenopausal women, n = 34.

g

Damgaard-Olesen et al. (2016), geometric mean, n = 72, age 30-<40.

h

Vandenput et al. (2007), interquartile range, n = 1086, age interquartile range 18.4–19.3.

i

Turcu et al. (2016), interquartile range, combined values for 19 men and 19 women, age 3-59.

j

Sanchez-Guijo et al. (2016), interquartile range estimated from Fig. 2, n = 60, age range 18–60.